Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

of the Board of Managing Directors Chief Executive Chief Executive Officer and Editor-in-Chief Clarence James Gamble Professor of Economics and Demography Chief Executive Officer Dean Deputy Managing Editor Founder and Chief Executive Officer Member of the Board, Chief Financial Officer and Chairm

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

nnual Meeting 2011 EFTA_R1_02011048 EFTA02686173 David E. Bloom Clarence James Gamble Professor of Harvard School of Public USA Economics and Demography Health Kathy Bloomgarden Chief Executive Officer Ruder Finn Inc. USA Sally Blount Dean Kellogg School of USA Management Rebecca Blumenstei

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

nnual Meeting 2011 EFTA_R1_02011167 EFTA02686250 David E. Bloom Clarence James Gamble Professor of Harvard School of Public USA Economics and Demography Health Kathy Bloomgarden Chief Executive Officer Ruder Finn Inc. USA Sally Blount Dean Kellogg School of USA Management Rebecca Blumenstei

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

ild Germany World Economic Forum Annual Meeting EFTA_R1_02105159 EFTA02707391 David E. Bloom Clarence James Gamble Professor of Economics and Demography Chief Executive Officer Harvard School of Public USA Health Ruder Finn Inc. USA Kathy Bloomgarden Kurt Bock Michael C. Bodson David Boehmer